Articles published by GlobeNewswire
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
September 29, 2025
From Royalty Pharma plc
Via GlobeNewswire
Tickers
RPRX
Getty Images Announces Proposed Offering of Senior Secured Notes due 2030
September 29, 2025
Via GlobeNewswire
Tickers
GETY
Candel Therapeutics Presents Phase 3 Clinical Trial of CAN-2409 in Localized Prostate Cancer at ASTRO 2025
September 29, 2025
From Candel Therapeutics
Via GlobeNewswire
Tickers
CADL
CSX Corp. Announces Leadership Transition
September 29, 2025
From CSX Corporation
Via GlobeNewswire
Tickers
CSX
Via GlobeNewswire
Tickers
ELTX
Levy to Succeed Krinick as Rivkin Radler Managing Partner
September 29, 2025
From Rivkin Radler LLP
Via GlobeNewswire
NBCUniversal and DraftKings Enter Multi-Year Collaboration Across Expansive Sports Portfolio
September 29, 2025
Via GlobeNewswire
Tickers
DKNG
Lumanity Introduces Groundbreaking Value Framework to Transform Biopharma Commercialization
September 29, 2025
From Lumanity
Via GlobeNewswire
Rezolve Ai Clarifies Recent SEC Filing and Reaffirms Strategic Growth Initiatives
September 29, 2025
From Rezolve AI Ltd
Via GlobeNewswire
Tickers
RZLV
FAVO Capital Appoints Dr. Wael Barsoum as Independent Director
September 29, 2025
From FAVO Capital, Inc.
Via GlobeNewswire
Tickers
FAVO
Apollo Announces Launch of Apollo Sports Capital
September 29, 2025
Via GlobeNewswire
Tickers
APO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.